🇺🇸 Hepatitis B Vaccine in United States

407 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Fatigue — 58 reports (14.25%)
  2. Dyspnoea — 46 reports (11.3%)
  3. Diarrhoea — 45 reports (11.06%)
  4. Nausea — 41 reports (10.07%)
  5. Headache — 40 reports (9.83%)
  6. Arthralgia — 39 reports (9.58%)
  7. Pyrexia — 36 reports (8.85%)
  8. Vomiting — 35 reports (8.6%)
  9. Pain — 34 reports (8.35%)
  10. Dizziness — 33 reports (8.11%)

Source database →

Hepatitis B Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Hepatitis B Vaccine approved in United States?

Hepatitis B Vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hepatitis B Vaccine in United States?

Murdoch Childrens Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.